Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

7 big buy ratings: ACM Research surges on upgrade | Pro Recap

Published 07/03/2023, 11:02
Updated 07/03/2023, 11:02
© Reuters.

© Reuters.

By Davit Kirakosyan

Investing.com -- Here is your daily Pro Recap of the analysts' biggest positive rating moves you may have missed on InvestingPro. Start your free 7-day trial to get this news first.

ACM Research pops on Morgan Stanley upgrade

ACM Research (NASDAQ:ACMR) shares surged more than 10% yesterday after Morgan Stanley upgraded the stock to Overweight from Underweight and raised its price target to $13.50 from $10.00, noting that the company should enjoy a strong year of growth in 2023, supported by market share gains and new product launches.

"We believe those should be able to offset business headwinds from China's 2023 WFE TAM decline," added the firm.

Hesai Group rated Overweight

Morgan Stanley initiated coverage on Hesai Group (NASDAQ:HSAI) with an Overweight rating and a price target of $26.50. Shares were down more than 2% pre-market today, below last month's IPO price.

Five more positive analyst moves

KeyBanc upgraded Kimbell Royalty Partners (NYSE:KRP) to Overweight from Sector Weight with a price target of $21.00. Shares gained more than 3% pre-market today.

Redburn upgraded Monster Beverage (NASDAQ:MNST) to Buy from Neutral. The company reported its Q4 results last week, with EPS of $0.57 and revenue of $1.51 billion coming in worse than the consensus estimates of $0.63 and $1.6B, respectively.

Baird initiated coverage on bluebird bio (NASDAQ:BLUE) with an Outperform rating and a price target of $10.00. Shares rose more than 2% pre-market today.

Exane BNP Paribas upgraded United Airlines (NASDAQ:UAL) to Outperform from Underperform.

Piper Sandler upgraded Mercantile Bank (NASDAQ:MBWM) to Overweight from Neutral and raised its price target to $40.00 from $38.00.

InvestingPro | Be The First To Know

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.